Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 156 of 6351
-
World-First larynx transplant trial offers new hope for silent patients
Disease control Recruiting nowThe experience of face and hand composite tissue transplantations reported in the international community have mainly concerned trauma patients. Feasibility and individual benefit have been demonstrated for these indications, in properly selected patients. The first laryngeal tra…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a Two-Step stem cell transplant tame Graft-Versus-Host disease?
Cure CompletedThis phase II trial studies how well a 2-step approach to stem cell transplant works in treating patients with blood cancers. Giving chemotherapy and total body irradiation before a lymphocyte (white blood cell) and stem cell transplant helps stop the growth of cells in the bone …
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Cure
Last updated Jul 25, 2026 00:00 UTC
-
Engineered immune cells take on metastatic tumors in new trial
Disease control Recruiting nowBackground: A person s tumor is studied for mutations. When cells are found that can attack the mutation in a person s tumor, the genes from those cells are studied to find the parts that make the attack possible. White blood cells are then taken from the person s body, and the …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Lab-Grown blood vessels could save limbs after trauma
Disease control CompletedThis study evaluates the use of the Acellular Tissue Engineered Vessel (ATEV) in adults with vascular trauma below the neck who are undergoing vascular reconstructive surgery. There will be an extremity cohort and an torso cohort. All subjects will be implanted with an ATEV as an…
Phase 2/3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can fewer, stronger radiation doses match standard treatment after mastectomy?
Disease control CompletedThe study was designed to investigate whether hypofractionated adjuvant radiotherapy is noninferior to conventionally fractionated adjuvant radiotherapy in terms of efficacy and toxicities for high risk breast cancer patients treated with mastectomy
Sponsor: Fudan University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can an antiviral drug protect hearing in infants with congenital CMV?
Disease control Stopped earlyThe overall goal of this study is to determine the clinical benefit and safety of antiviral therapy for asymptomatic congenital cytomegalovirus (cCMV) infected hearing-impaired infants. We will conduct a multi-center double-blind randomized placebo-controlled trial to determine w…
Phase 2 • Sponsor: Albert Park • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Immunotherapy combo shows promise in advanced lung cancer trial
Disease control CompletedEfficacy and Safety Evaluation of IBI308 in Patients with advanced or metastatic Non-squamous NSCLC
Phase 3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Promising combo targets Leukemia's genetic weakness
Disease control CompletedThis is a randomized, multi-center, double-blind, placebo-controlled study designed to evaluate the efficacy of crenolanib administered following salvage chemotherapy, consolidation chemotherapy, post bone marrow transplantation and as maintenance in relapsed/refractory AML subje…
Phase 3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Targeted pill may outshine chemo after lung cancer surgery
Disease control OngoingThis randomized, active-controlled, multicenter, open-label, Phase III study is designed to investigate the efficacy and safety of alectinib compared with platinum-based in the adjuvant setting. Participants in the experimental arm will receive alectinib at 600 mg orally twice da…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug shows promise in leukemia battle
Disease control CompletedA phase III randomized multi-center study designed to compare the efficacy of crenolanib with that of midostaurin when administered following induction chemotherapy, consolidation chemotherapy and bone marrow transplantation in newly diagnosed AML subjects with FLT3 mutation. Abo…
Phase 3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug DS-8201a takes on standard therapy in advanced breast cancer trial
Disease control OngoingThis study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane.
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Mismatched donor stem cell transplant could widen treatment access for sickle cell disease
Disease control Recruiting nowThe purpose of this study is to evaluate what effect, if any, mismatched unrelated volunteer donor and/or haploidentical related donor stem cell transplant may have on severe sickle cell disease and other transfusion dependent anemias. By using mismatched unrelated volunteer dono…
Phase 1/2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before. Their cancer: * cannot be removed by an operation * has spread to other parts of the body
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Engineered immune cells take on tough childhood leukemia in new trial
Disease control OngoingSJCAR19 is a research study seeking to evaluate the use of chimeric antigen receptor (CAR) T cell therapy, a type of cellular therapy, for the treatment of pediatric, adolescent and young adult patients with relapsed or refractory CD19+ acute lymphoblastic leukemia (ALL). CAR the…
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for stage III lung cancer: targeted pill may delay progression
Disease control OngoingA global study to assess the efficacy and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non-small cell lung cancer
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can one shot replace six? a new vaccine aims to protect infants from six diseases at once
Vaccine CompletedThe purpose of this study is to evaluate immunogenicity and safety of different doses of candidate hexavalent vaccine in comparison to co-administration of Pentavalent vaccine and Poliomyelitis Vaccine (Inactivated) in separate injections at four weeks after completion of three-d…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
Can targeted radiation boost Immunotherapy's power against head and neck cancer?
Disease control CompletedImmunotherapy targeting the PD-1/PD-L1 pathway had previously been shown to be efficacious in the treatment of patients with metastatic head and neck squamous cell carcinomas. Stereotactic Body Radiotherapy (SBRT) to metastatic lesions causes localized cancer cell killing and the…
Phase 1/2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Blood test could spot hidden cancers in High-Risk patients
Diagnosis OngoingThe goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier ca…
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Can an immunotherapy combo shrink stomach tumors before surgery?
Disease control OngoingThis is a randomized, multicenter, controlled, adaptive phase II/III clinical study. The aim is to compare neoadjuvant chemotherapy with docetaxel, oxaliplatin, and S-1 (DOS) plus toripalimab versus oxaliplatin and S-1 (SOX) plus toripalimab in patients with locally advanced gast…
Phase 2/3 • Sponsor: Peking University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug outshines chemo in advanced bladder cancer trial
Disease control CompletedThe purpose of this study was to compare the overall survival (OS) of participants with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin (EV) to the OS of participants treated with chemotherapy. This study compared progression-free survival on stu…
Phase 3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC